Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.godavaridrugs.com | |
Market Cap | 66.23 Cr. | |
Enterprise Value(EV) | 99.73 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 5.03 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 17.49 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 33.57 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 44.38 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.98 | Calculated using Price: 87.95 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.75 Cr. | 7,530,500 Shares |
FaceValue | 10 | |
About Godavari Drugs Ltd. | ||
The company's principal activity is to manufacture and sell bulk drugs. It undertakes contract manufacturing from various organizations. The products include Pyrazinamide and Ethambutol HCL. |
1 Day |
|
-0.97% |
1 Week |
|
-3.71% |
1 Month |
|
+12.48% |
3 Month |
|
+9.70% |
6 Month |
|
+39.45% |
1 Year |
|
+28.97% |
2 Year |
|
+44.09% |
5 Year |
|
+214.91% |
10 Year |
|
+862.22% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 17.77 | 32.32 | 9.84 | 11.81 | 4.99 | 6.85 | 10.39 | 18.49 | 19.42 | |
Return on Capital Employed (%) | 8.18 | 32.30 | 15.77 | 16.89 | 11.01 | 12.14 | 11.80 | 17.58 | 18.35 | |
Return on Assets (%) | 10.41 | 14.70 | 3.17 | 3.41 | 1.40 | 1.77 | 2.54 | 4.72 | 5.45 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 10 | 13 | 14 | 16 | 17 | 18 | 20 | 24 | 30 | 33 | |
Non Curr. Liab. | 2 | 5 | 5 | 6 | 9 | 9 | 12 | 16 | 14 | 14 | |
Curr. Liab. | 3 | 17 | 31 | 34 | 37 | 46 | 51 | 51 | 58 | 74 | |
Minority Int. | |||||||||||
Equity & Liab. | 15 | 35 | 51 | 56 | 63 | 74 | 84 | 91 | 101 | 121 | |
Non Curr. Assets | 8 | 8 | 10 | 13 | 16 | 17 | 23 | 24 | 27 | 34 | |
Curr. Assets | 6 | 27 | 40 | 43 | 47 | 56 | 61 | 68 | 74 | 87 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 15 | 35 | 51 | 56 | 63 | 74 | 84 | 91 | 101 | 121 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 9 | 55 | 71 | 76 | 64 | 84 | 96 | 123 | 161 | 160 | |
Other Income | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | |
Total Income | 10 | 55 | 71 | 76 | 65 | 84 | 96 | 123 | 161 | 160 | |
Total Expenditure | -8 | -49 | -67 | -70 | -60 | -78 | -90 | -113 | -150 | -150 | |
PBIDT | 2 | 6 | 5 | 6 | 5 | 6 | 6 | 10 | 12 | 11 | |
Interest | 0 | -1 | -2 | -3 | -2 | -3 | -3 | -3 | -3 | -4 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | |
Taxation | 1 | -1 | -1 | -1 | 0 | -1 | 0 | -2 | -2 | -1 | |
Exceptional Items | 0 | ||||||||||
PAT | 2 | 4 | 1 | 2 | 1 | 1 | 2 | 4 | 5 | 4 | |
Adjusted EPS | 2 | 5 | 2 | 2 | 1 | 2 | 3 | 5 | 7 | 5 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 2 | -6 | -5 | 5 | 4 | 4 | 6 | 1 | 11 | |
Cash Fr. Inv. | -1 | -2 | 0 | -2 | -3 | -3 | -2 | -7 | -1 | -5 | |
Cash Fr. Finan. | 1 | 0 | 6 | 7 | -2 | 0 | -1 | 0 | 0 | -6 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 2 | 2 |
Thu, 08 Jun 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sushma Kakani |
Thu, 08 Jun 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prashant Shrimal |
Thu, 08 Jun 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mohit Jaju |
Fri, 09 Jun 2023 |
|
|
S Making Lower Lows for 2 Days |
|
|